盐酸氟安定结构式
|
常用名 | 盐酸氟安定 | 英文名 | Flurazepam dihydrochloride |
|---|---|---|---|---|
| CAS号 | 1172-18-5 | 分子量 | 460.80000 | |
| 密度 | N/A | 沸点 | 551.4ºC at 760mmHg | |
| 分子式 | C21H25Cl3FN3O | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 287.2ºC | |
| 符号 |
GHS07, GHS08 |
信号词 | Warning |
盐酸氟安定用途1.适用于各种抑郁性精神障碍。 |
| 中文名 | 盐酸氟安定 |
|---|---|
| 英文名 | Flurazepam Dihydrochloride |
| 中文别名 | 盐酸氟西洋 |
| 英文别名 | 更多 |
| 沸点 | 551.4ºC at 760mmHg |
|---|---|
| 分子式 | C21H25Cl3FN3O |
| 分子量 | 460.80000 |
| 闪点 | 287.2ºC |
| 精确质量 | 459.10500 |
| PSA | 35.91000 |
| LogP | 5.10950 |
| 外观性状 | solid | light yellow |
| 蒸汽压 | 3.34E-12mmHg at 25°C |
| 储存条件 | 2-8°C |
| 水溶解性 | 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: <6 mg/mL |
| 计算化学 | 1.疏水参数计算参考值（XlogP）:无 2.氢键供体数量:2 3.氢键受体数量:4 4.可旋转化学键数量:6 5.互变异构体数量:2 6.拓扑分子极性表面积35.9 7.重原子数量:29 8.表面电荷:0 9.复杂度:540 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:3 |
| 更多 | 1.性状：浅黄色固体。 |
| 符号 |
GHS07, GHS08 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H302-H373 |
| 警示性声明 | P260-P301 + P312 + P330 |
| 个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
| 危害码 (欧洲) | Xn: Harmful; |
| 风险声明 (欧洲) | R22 |
| 安全声明 (欧洲) | S1/2-S22-S36-S36/37/39 |
| 危险品运输编码 | 3249 |
| WGK德国 | 3 |
| RTECS号 | DF0875000 |
| 包装等级 | III |
| 危险类别 | 6.1(b) |
| 盐酸氟安定上游产品 0 | |
|---|---|
| 盐酸氟安定下游产品 2 | |
|
Folie à deux: a case report.
Clin. Schizophr. Relat. Psychoses 7(2) , 93-6, (2013) Folie à deux is a relatively rare mental disorder first described in France in 1877 by Lasègue and Falret. However, folie à deux is still a matter of study and debate today as it remains a challenge f... |
|
|
LC-MS/MS analysis of 13 benzodiazepines and metabolites in urine, serum, plasma, and meconium.
Methods Mol. Biol. 603 , 89-105, (2010) We describe a single method for the detection and quantitation of 13 commonly prescribed benzodiazepines and metabolites: alpha-hydroxyalprazolam, alpha-hydroxyethylflurazepam, alpha-hydroxytriazolam,... |
|
|
Gender differences in highway driving performance after administration of sleep medication: a review of the literature.
Traffic Inj. Prev. 13(3) , 286-92, (2012) It is generally assumed that there are minimal gender differences in the safety and efficacy of central nervous system drugs, as is evidenced by men and women receiving the same drug dosage. There is,... |
| 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one,dihydrochloride |
| EINECS 214-630-0 |
| MFCD00058189 |
CAS号20971-53-3
CAS号2886-65-9